ABBV vs TECH
AbbVie Inc (ABBV) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ABBV and TECH stock pages for the full models.
Not investment advice.